Ulf Nihlén

1.9k total citations
39 papers, 980 citations indexed

About

Ulf Nihlén is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ulf Nihlén has authored 39 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 19 papers in Physiology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ulf Nihlén's work include Chronic Obstructive Pulmonary Disease (COPD) Research (24 papers), Asthma and respiratory diseases (19 papers) and Respiratory and Cough-Related Research (11 papers). Ulf Nihlén is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (24 papers), Asthma and respiratory diseases (19 papers) and Respiratory and Cough-Related Research (11 papers). Ulf Nihlén collaborates with scholars based in Sweden, United Kingdom and Australia. Ulf Nihlén's co-authors include Peter Montnémery, Gunnar Engström, Per Nyberg, Sophia Frantz, Per Wollmer, C.‐G. Löfdahl, Magnus Dencker, Emilie Stroh, Anna Axmon and Anna Lindgren and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and European Respiratory Journal.

In The Last Decade

Ulf Nihlén

37 papers receiving 942 citations

Peers

Countries citing papers authored by Ulf Nihlén

Since Specialization

Citations

This map shows the geographic impact of Ulf Nihlén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Nihlén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Nihlén more than expected).

Fields of papers citing papers by Ulf Nihlén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Nihlén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Nihlén. The network helps show where Ulf Nihlén may publish in the future.

Co-authorship network of co-authors of Ulf Nihlén

This figure shows the co-authorship network connecting the top 25 collaborators of Ulf Nihlén. A scholar is included among the top collaborators of Ulf Nihlén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulf Nihlén. Ulf Nihlén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhomogeneity of ventilation in smokers and mild COPD assessed by the ratio of alveolar volume to total lung capacity 2024 ·Respiratory Medicine ·(unknown), Suneela Zaigham, Sophia Frantz, Ulf Nihlén, Per Wollmer, Viktor Hamrefors	1
2	Single-nucleotide polymorphisms in the sulfatase-modifying factor 1 gene are associated with lung function and COPD 2022 ·ERJ Open Research ·(unknown), Sophia Frantz, Julie Weidner, Jaro Ankerst, Ulf Nihlén, Leif Bjermer, Per Wollmer, Ellen Tufvesson	4
3	A new protocol for exercise testing in COPD; improved prediction algorithm for W_MAX and validation of the endurance test in a placebo-controlled double bronchodilator study 2021 ·Therapeutic Advances in Respiratory Disease ·Ellen Tufvesson, Finn Radner, (unknown), (unknown), (unknown), (unknown), Ulf Nihlén, Alf Tunsäter, Jaro Ankerst, Stefan Peterson, Leif Bjermer, (unknown)	1
4	<p>Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD</p> 2020 ·International Journal of COPD ·Ellen Tufvesson, Finn Radner, (unknown), (unknown), (unknown), Ulf Nihlén, Jaro Ankerst, Alf Tunsäter, Stefan Peterson, Leif Bjermer, (unknown)	1
5	Fixed ratio or lower limit of normal for the FEV1/VC ratio: Relation to symptoms and extended lung function tests 2013 ·European Respiratory Journal ·Sophia Frantz, Per Wollmer, Gunnar Engström, Magnus Dencker, Claes‐Göran Löfdahl, Ulf Nihlén	4
6	Associations between lung function and alcohol consumption – Assessed by both a questionnaire and a blood marker 2013 ·Respiratory Medicine ·Sophia Frantz, Per Wollmer, Magnus Dencker, Gunnar Engström, Ulf Nihlén	24
7	Impulse oscillometry may be of value in detecting early manifestations of COPD 2012 ·Respiratory Medicine ·Sophia Frantz, Ulf Nihlén, Magnus Dencker, Gunnar Engström, C.-G. Löfdahl, Per Wollmer	107
8	Blood biomarkers and measures of pulmonary function–A study from the Swedish twin registry 2012 ·Respiratory Medicine ·Gunnar Engström, Claes Lindberg, Maria Gerhardsson de Verdier, Ulf Nihlén, Martin Anderson, Magnus Svartengren, Kristina Forsman‐Semb	15
9	Total desmosines in plasma and urine correlate with lung function 2011 ·European Respiratory Journal ·(unknown), Gunnar Engström, Maria Gerhardsson de Verdier, Ulf Nihlén, Martin Anderson, Kristina Forsman‐Semb, Magnus Svartengren	41
10	Genetic and environmental influence on lung function impairment in Swedish twins 2010 ·Respiratory Research ·Jenny Hallberg, Anastasia Iliadou, Martin Anderson, Maria Gerhardsson de Verdier, Ulf Nihlén, Magnus Dahlbäck, Nancy L. Pedersen, Tim Higenbottam, Magnus Svartengren	23
11	Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD 2010 ·Respiratory Medicine ·H. Worth, Karin Förster, Göran Eriksson, Ulf Nihlén, Stefan Peterson, H Magnussen	35
12	Specific nasal symptoms and symptom‐provoking factors may predict increased risk of developing COPD 2008 ·Clinical Physiology and Functional Imaging ·Ulf Nihlén, Peter Montnémery, Morgan Andersson, C. G. A. Persson, Per Nyberg, Claes‐Göran Löfdahl, Lennart Greiff	19
13	Interaction between Smoking and Genetic Factors in the Development of Chronic Bronchitis 2007 ·American Journal of Respiratory and Critical Care Medicine ·Jenny Hallberg, (unknown), Ulrika K. Eriksson, Maria Gerhardsson de Verdier, Nancy L. Pedersen, Magnus Dahlbäck, Ulf Nihlén, Tim Higenbottam, Magnus Svartengren	38
14	Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease 2005 ·Respiratory Medicine ·(unknown), A Eliraz, Gunnar Johansson, Göran Tornling, Ulf Nihlén, Thomas Bengtsson, Klaus F. Rabe	68
15	Prevalence of Hand Eczema in an Adult Swedish Population and the Relationship to Risk Occupation and Smoking 2005 ·Acta Dermato Venereologica ·Peter Montnémery, Ulf Nihlén, C.‐G. Löfdahl, Per Nyberg, Åke Svensson	55
16	Formoterol used as needed in patients with intermittent or mild persistent asthma 2004 ·Respiratory Medicine ·А. Г. Чучалин, (unknown), Thomas Bengtsson, Ulf Nihlén, Johan Rosenborg	11
17	Nasal neutrophil activity and mucinous secretory responsiveness in COPD 2003 ·Clinical Physiology and Functional Imaging ·Ulf Nihlén, Morgan Andersson, Claes‐Göran Löfdahl, C. G. A. Persson, Peter Montnémery, Lennart Greiff	15
18	Influence of family history and smoking habits on the incidence of self-reported physician's diagnosis of COPD 2003 ·Respiratory Medicine ·Ulf Nihlén, Per Nyberg, Peter Montnémery, Claes‐Göran Löfdahl	27
19	Prevalence of self-reported eczema in relation to living environment, socio-economic status and respiratory symptoms assessed in a questionnaire study 2003 ·BMC Dermatology ·Peter Montnémery, Ulf Nihlén, C.‐G. Löfdahl, Per Nyberg, Åke Svensson	49
20	Increased serum levels of carbohydrate-deficient transferrin in patients with chronic obstructive pulmonary disease 2001 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Ulf Nihlén, Peter Montnémery, Lars Lindholm, C.‐G. Löfdahl	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact